Evidence map›Paper›PMID 41078364›Full record

ArticleFrontiers in cellular and infection microbiology2025

Propionic acid mediates the renoprotective effects of fecal microbiota transplantation against ischemia-reperfusion injury via upregulating GPR43.

Jingxuan Yu, Zhenyu Liu, Yan Wang, Yu Zhou, Wei Liu, Tao Wang, Qiubo Xie, Hongzhe Tian, Yalong Xu, Min Wang and 6 more

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jingxuan Yu *Department of Urology, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, Hubei, China.
Zhenyu Liu *Department of Urology, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, Hubei, China.
Yan Wang *Department of Urology, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, Hubei, China.
Yu ZhouDepartment of Urology, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, Hubei, China.
Wei LiuDepartment of Urology, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, Hubei, China.
Tao WangDepartment of Urology, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, Hubei, China.
Qiubo XieDepartment of Urology, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, Hubei, China.
Hongzhe TianDepartment of Urology, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, Hubei, China.
Yalong XuDepartment of Urology, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, Hubei, China.
Min WangDepartment of Urology, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, Hubei, China.
Fuhan ZhaoDepartment of Urology, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, Hubei, China.
Lin WangDepartment of Urology, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, Hubei, China.
Guan ZhangDepartment of Urology, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, Hubei, China.
Dongliang ChenChina Peptide and Life Science Research Institute, Wuhan, Hubei, China.
Lei GaoDepartment of Urology, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, Hubei, China.
Tiejun PanDepartment of Urology, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Kidney ischemia-reperfusion injury (IRI) is a major cause of acute kidney injury (AKI), characterized by aggravated inflammation and apoptosis following reperfusion. This study aimed to investigate the protective effects and mechanisms of fecal microbiota transplantation (FMT) in a rat model of kidney IRI. Methods: Sprague-Dawley rats(SDRs) subjected to 45 minutes of bilateral renal ischemia followed by reperfusion were prophylactically treated with FMT derived from guinea pigs or supplemented with propionic acid. Renal function, histopathology, inflammatory markers, apoptosis, proliferation, and gut microbiota composition were systematically evaluated. Results: The results demonstrated that FMT attenuated kidney IRI by remodeling the gut microbiota to enhance propionic acid production, which subsequently modulated inflammation and apoptosis via GPR43 signaling. Conclusions: These findings provide novel insights into microbiota-targeted therapeutic strategies for kidney IRI and highlight propionic acid as a potential therapeutic agent.

Indexed as

Acute Kidney InjuryFecal Microbiota TransplantationPropionatesReceptors, G-Protein-CoupledReperfusion InjuryAnimalsApoptosisDisease Models, AnimalGastrointestinal MicrobiomeGuinea PigsKidneyMaleRatsRats, Sprague-DawleySignal TransductionUp-RegulationFfar2 protein, ratPropionatespropionic acidReceptors, G-Protein-Coupledacute kidney injuryfecal microbiota transplantationischemia-reperfusion injuryLachnospiraceaeshort-chain fatty acids

Identifiers

PMID41078364
PMCPMC12507785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.